Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
Characterization of human platelet binding of recombinant T cell receptor ligand.
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.
Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
The impact of environmental infections (parasites) on MS activity.
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Endogenous retroviruses and multiple sclerosis--new pieces to the puzzle.
Subcellular distribution of FTY720 and FTY720-phosphate in immune cells - another aspect of Fingolimod action relevant for therapeutic application.
Psoriasis during natalizumab treatment for multiple sclerosis.
Transverse myelitis associated with heroin and cannabis abuse: a new issue from the past.
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
Mutations affecting segment number and polarity in Drosophila.
Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging.
Natalizumab for the prevention of post-partum relapses in women with multiple sclerosis.
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy.
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis.
Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
High risk of MS in Iranian immigrants in Gothenburg, Sweden.

Pages